Please note that slides are for review only and not to be repurposed or published.

Meet The Professors: Clinical Investigators Provide Perspectives on the Integration of Immune Checkpoint Inhibitors into the Management of Small Cell Lung Cancer

MODULE 1:
Current and Future Management of Newly Diagnosed Extensive-Stage Small Cell Lung Cancer (ES-SCLC) — Dr Spigel

MODULE 2:
Management of Progressive ES-SCLC — Dr Govindan

MODULE 3:
Recognition and Management of Immune-Related Adverse Events with Immune Checkpoint Inhibitor Therapy in SCLC — Dr Farago

Live Poll Results
Download

Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum

Slide Presentation
Download

Live Poll Results
Download